Omalizumab for severe allergic asthma in clinical trials and real-life studies: what we know and what we should address. (Q38339722)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Omalizumab for severe allergic asthma in clinical trials and real-life studies: what we know and what we should address. |
scientific article |
Statements
Omalizumab for severe allergic asthma in clinical trials and real-life studies: what we know and what we should address (English)
Marco Caminati
Anna Rita Dama
Fulvia Chieco-Bianchi
Giorgia Stefanizzi
Marcello Montagni
Erminia Ridolo
30 January 2015